Baker Bros. Advisors Lp, Ten Percent Owner at BioCryst, holds 6.00M shares in Kymera Therapeutics (Ticker: KYMR), holds 3.76M shares in IGM Biosciences (Ticker: IGMS), holds 28.78M shares in Incyte (Ticker: INCY). Most recently, Baker Bros. Advisors Lp Bought ― shares of Kymera Therapeutics on Aug 22, 2024 for an estimated value of 46.41.
What was Baker Bros. Advisors Lp’s latest transaction?
Baker Bros. Advisors Lp latest transaction was an Informative Buy of $46.41.
What was Baker Bros. Advisors Lp's most profitable transaction?
Baker Bros. Advisors Lp’s most profitable transaction was an Informative Buy of NVTAQ stock on March 29, 2018. The return on the trade was 399.30%.
What is Baker Bros. Advisors Lp's role in BioCryst?
Baker Bros. Advisors Lp's role in BioCryst is Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.